recombinant herpesvirus vector vaccine (National Institute of Biomedical Innovation)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant herpesvirus vector vaccine (National Institute of Biomedical Innovation)
Drug Alias Namerecombinant polyvalent varicella zoster virus vaccine (National Institute of Biomedical Innovation)recombinant polyvalent VZV vaccine (National Institute of Biomedical Innovation)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Biomedical Innovation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Biomedical InnovationOsaka University
Active IndicationsN/A
Inactive IndicationsHerpesviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A